Special Report: Melbourne biotech company Dimerix (ASX:DXB) expects to receive readouts on three phase 3 studies in the near term … Read More
The post Dimerix has three ‘shots on goal’ next year appeared first on Stockhead.
Barry Stroman was a reporter for Zerg Watch, before becoming the lead editor. Barry has previously worked for Wired, MacWorld, PCWorld, and VentureBeat covering countless stories concerning all things related to tech and science. Barry studied at NYU.